Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.24%
SPX
+0.22%
IXIC
+0.32%
FTSE
+0.11%
N225
+0.90%
AXJO
-0.12%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

About

What does CLDX do?
Celldex Therapeutics, based in Hampton, New Jersey, develops novel therapeutics targeting mast cell-mediated diseases and employs 160 staff. Their pipeline includes Barzolvolimab and the bispecific antibody CDX-585 for inflammatory diseases and oncology.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New Jersey, USA
Website
http://www.celldex.com

Key Stats

Market Cap
1.33B
Dividend Yield
0.00%
P/E Ratio
-7.45
EPS
-2.45
Revenue
7.02M
Avg. Volume
722.80K

Recently from Cashu

publisher logo
Cashu

Celldex Therapeutics (CLDX): Analyst Views Reveal Mixed Sentiment on Future Prospects

2 days ago
publisher logo
Cashu

Celldex Therapeutics Gains 'Overweight' Rating from Morgan Stanley Amid Promising Pipeline

3 months ago
Stocks
Health Care
cldx
Celldex Therapeutics
CLDX
+0.61 (+3.04%)
20.67
USD
At close at Jun 18, 18:05 UTC
Summary
News
Signals
Benchmarks
Financials